549. Switching the Fiber Knob of Oncolytic Adenoviruses to Avoid Neutralizing Antibodies in Human Cancer Patients

Molecular Therapy - United States
doi 10.1016/s1525-0016(16)37990-4
Full Text
Abstract

Available in full text

Date
Authors

Unknown

Publisher

Elsevier BV

Related search

Seroprevalence of Neutralizing Antibodies Against Human Adenovirus Type-5 and Chimpanzee Adenovirus Type-68 in Cancer Patients

Frontiers in Immunology
AllergyImmunology
2018English

Measles Virus Glycoprotein-Based Lentiviral Targeting Vectors That Avoid Neutralizing Antibodies

PLoS ONE
Multidisciplinary
2012English

GP73-regulated Oncolytic Adenoviruses Possess Potent Killing Effect on Human Liver Cancer Stem-Like Cells

Oncotarget
Oncology
2016English

Analysis of Predictive and Prognostic Factors in 290 Patients Treated With Oncolytic Adenoviruses

Journal for ImmunoTherapy of Cancer
OncologyMolecular MedicinePharmacologyCancer ResearchAllergyImmunology
2015English

T-Cell Subsets in Peripheral Blood and Tumors of Patients Treated With Oncolytic Adenoviruses

Molecular Therapy
Molecular MedicineMolecular BiologyPharmacologyMedicineGeneticsDrug Discovery
2015English

Antagonism of Glycolysis and Reductive Carboxylation of Glutamine Potentiates Activity of Oncolytic Adenoviruses in Cancer Cells

Cancer Research
Cancer ResearchOncology
2018English

Humanization of the Murine Neutralizing Antibodies Against Human Herpesvirus 6B

Journal of Virology
Insect ScienceImmunologyMicrobiologyVirology
2019English

Going Viral: A Review of Replication-Selective Oncolytic Adenoviruses

Oncotarget
Oncology
2015English

Identification of Human Neutralizing Antibodies That Bind to Complex Epitopes on Dengue Virions

Proceedings of the National Academy of Sciences of the United States of America
Multidisciplinary
2012English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy